AJIT SHAH, MD
Nuclear Medicine Physician · LEXINGTON, KY
Individual Active NPI 1245227735
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 313 | 455 | $685,571 | $205,333 | $163,399 |
| 2023 | 316 | 394 | $367,973 | $96,916 | $76,892 |
| 2022 | 308 | 344 | $90,393 | $22,545 | $17,087 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 78264 | Nuclear medicine study of stomach to assess emptying | 62 | $35 | $27 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 58 | $195 | $155 |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 58 | $1,476 | $1,180 |
| 78226 | Nuclear medicine study of liver and bile duct system | 35 | $33 | $26 |
| 78582 | Nuclear medicine study of lung ventilation and circulation | 34 | $46 | $36 |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 33 | $48 | $37 |
| 78306 | Nuclear medicine study of bone and/or joint whole body | 29 | $38 | $27 |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | 25 | $40 | $31 |
| 78814 | Nuclear medicine study limited area with ct scan | 18 | $1,487 | $1,186 |
| Q9983 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 17 | $2,755 | $2,195 |
| 78315 | Nuclear medicine study of bone taken at different times | 12 | $46 | $30 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nuclear Medicine Physician | 207U00000X | ✓ | TP163 | KY |
| Diagnostic Radiology Physician | 2085R0202X | MD036456E | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Nuclear Medicine Physician providers in Kentucky
- NPI 1275558314
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.